[go: up one dir, main page]

AP9100285A0 - Substituted benzimidazoles,process for their preparation and their pharmaceutical use - Google Patents

Substituted benzimidazoles,process for their preparation and their pharmaceutical use

Info

Publication number
AP9100285A0
AP9100285A0 AP91/00285A AP9100285A AP9100285A0 AP 9100285 A0 AP9100285 A0 AP 9100285A0 AP 91/00285 A AP91/00285 A AP 91/00285A AP 9100285 A AP9100285 A AP 9100285A AP 9100285 A0 AP9100285 A0 AP 9100285A0
Authority
AP
ARIPO
Prior art keywords
preparation
pharmaceutical use
substituted benzimidazoles
benzimidazoles
substituted
Prior art date
Application number
AP91/00285A
Other versions
AP215A (en
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of AP9100285A0 publication Critical patent/AP9100285A0/en
Application granted granted Critical
Publication of AP215A publication Critical patent/AP215A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
APAP/P/1991/000285A 1990-06-20 1991-06-19 Substituted benzimidazoles, process for their preparation and their pharmaceutical use. AP215A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002206A SE9002206D0 (en) 1990-06-20 1990-06-20 NEW COMPOUNDS

Publications (2)

Publication Number Publication Date
AP9100285A0 true AP9100285A0 (en) 1991-07-31
AP215A AP215A (en) 1992-09-02

Family

ID=20379831

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1991/000285A AP215A (en) 1990-06-20 1991-06-19 Substituted benzimidazoles, process for their preparation and their pharmaceutical use.

Country Status (27)

Country Link
EP (1) EP0535081A1 (en)
JP (1) JPH05507713A (en)
CN (1) CN1058212A (en)
AP (1) AP215A (en)
AU (1) AU649453B2 (en)
BG (1) BG97200A (en)
CA (1) CA2083714A1 (en)
CZ (1) CZ279772B6 (en)
FI (1) FI925766A7 (en)
HU (1) HUT62881A (en)
IE (1) IE912025A1 (en)
IL (1) IL98470A0 (en)
IS (1) IS3721A7 (en)
LT (2) LT3952B (en)
LV (1) LV10953A (en)
MA (1) MA22199A1 (en)
NO (1) NO924775D0 (en)
NZ (1) NZ238546A (en)
OA (1) OA09682A (en)
PT (1) PT98035A (en)
RO (1) RO110493B1 (en)
SE (1) SE9002206D0 (en)
TN (1) TNSN91049A1 (en)
TW (1) TW216418B (en)
WO (1) WO1991019711A1 (en)
YU (1) YU104191A (en)
ZA (2) ZA914297B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (en) * 1990-06-07 1990-06-07 Astra Ab IMPROVED METHOD FOR SYNTHESIS
SE9103776D0 (en) * 1991-12-19 1991-12-19 Astra Ab NEW COMPOUNDS
IS4232A (en) * 1993-12-06 1995-06-07 Astra Aktiebolag Substituted benzimidazole, its methods of manufacture and pharmacological use
SE504459C2 (en) * 1994-07-15 1997-02-17 Astra Ab Process for the preparation of substituted sulfoxides
SE9500422D0 (en) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (en) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
SE9600070D0 (en) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
AU2000254245B2 (en) 2000-02-24 2005-03-03 Kopran Research Laboratories Limited Orally administrable acid stable anti-ulcer benzimidazole derivatives
SE0101379D0 (en) 2001-04-18 2001-04-18 Diabact Ab Composition that inhibits gastric acid secretion
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
ES2320438T7 (en) 2002-04-09 2013-02-14 Flamel Technologies Oral pharmaceutical formulation of aqueous suspension of microcapsules that allow the modified release of active ingredient (s)
SE0203065D0 (en) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
KR20060092255A (en) 2003-09-26 2006-08-22 알자 코포레이션 Drug coating agent providing a high drug load and a method of manufacturing the same
TW200606163A (en) 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070015782A1 (en) 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
WO2007122686A1 (en) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. Benzimidazole compounds
CA2658804A1 (en) 2006-07-25 2008-01-31 Vecta Ltd. Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with ppi
US20110009624A9 (en) * 2006-10-13 2011-01-13 Masato Ueda Benzimidazole compounds having gastric acid secretion inhibitory action
MX2011002515A (en) 2008-09-09 2011-04-07 Astrazeneca Ab Method for delivering a pharmaceutical composition to patient in need thereof.
SG176724A1 (en) 2009-06-25 2012-01-30 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080501A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
EP2797600A4 (en) 2011-12-28 2015-09-16 Pozen Inc Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
AU2017326359B2 (en) 2016-09-14 2021-02-04 National Chiao Tung University Novel substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (en) 1974-02-18 1981-07-06 Haessle Ab ANALOGY PROCEDURE FOR THE PREPARATION OF COMPOUNDS WITH Gastric Acid Secretion Inhibitory Effects
SE416649B (en) 1974-05-16 1981-01-26 Haessle Ab PROCEDURE FOR THE PREPARATION OF SUBSTANCES WHICH PREVENT Gastric acid secretion
IN148930B (en) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (en) 1978-04-14 1979-10-15 Haessle Ab Gastric acid secretion
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (en) 1980-08-21 1984-07-13 Hoffmann La Roche IMIDAZOLE DERIVATIVES.
SE8300736D0 (en) 1983-02-11 1983-02-11 Haessle Ab NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS
SE8301182D0 (en) 1983-03-04 1983-03-04 Haessle Ab NOVEL COMPOUNDS
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US4738975A (en) 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
SE8505112D0 (en) * 1985-10-29 1985-10-29 Haessle Ab NOVEL PHARMACOLOGICAL COMPOUNDS
NZ222495A (en) 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
DE3722810A1 (en) * 1987-07-10 1989-01-19 Hoechst Ag SUBSTITUTED BENZIMIDAZOLES, METHOD FOR THE PRODUCTION THEREOF, THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THE USE THEREOF
WO1989003829A1 (en) * 1987-10-30 1989-05-05 Aktiebolaget Hässle Omeprazole for treatment of diseases related to bone loss
WO1989005299A1 (en) * 1987-12-11 1989-06-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel benzimidazole derivatives
AU3690289A (en) * 1988-05-25 1989-12-12 Byk Gulden Lomberg Chemische Fabrik Gmbh New fluoralkoxy compounds

Also Published As

Publication number Publication date
FI925766A0 (en) 1992-12-18
NO924775L (en) 1992-12-10
JPH05507713A (en) 1993-11-04
EP0535081A1 (en) 1993-04-07
NO924775D0 (en) 1992-12-10
LTIP1712A (en) 1995-08-25
MA22199A1 (en) 1992-04-01
HU9204033D0 (en) 1993-03-29
CA2083714A1 (en) 1991-12-21
CN1058212A (en) 1992-01-29
OA09682A (en) 1993-05-15
SE9002206D0 (en) 1990-06-20
IL98470A0 (en) 1992-07-15
LTIP1713A (en) 1995-08-25
WO1991019711A1 (en) 1991-12-26
HUT62881A (en) 1993-06-28
AU8009791A (en) 1992-01-07
FI925766A7 (en) 1992-12-18
IE912025A1 (en) 1992-01-01
LV10953A (en) 1995-12-20
AP215A (en) 1992-09-02
TW216418B (en) 1993-11-21
ZA914296B (en) 1992-03-25
IS3721A7 (en) 1991-12-21
RO110493B1 (en) 1996-01-30
LT3952B (en) 1996-05-27
LT3977B (en) 1996-06-25
ZA914297B (en) 1992-03-25
TNSN91049A1 (en) 1992-10-25
CZ279772B6 (en) 1995-06-14
NZ238546A (en) 1994-03-25
CS189491A3 (en) 1992-04-15
BG97200A (en) 1993-12-24
AU649453B2 (en) 1994-05-26
YU104191A (en) 1994-01-20
PT98035A (en) 1992-03-31

Similar Documents

Publication Publication Date Title
LTIP1712A (en) Substituted benzimidazoles, process for their preparation and their pharmaceutical use
IL98472A0 (en) Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use
EP0468372A3 (en) Substituted azoles, process for their preparation and their use
IL92798A0 (en) Benzimidazole derivatives,process for their preparation and pharmaceutical compositions containing them
EP0412848A3 (en) Quinoline derivatives, process for their preparation and their use as medicaments
EP0412350A3 (en) Renininhibitors, procedure for their preparation and use as medicaments
LTIP709A (en) Sbstituted corticoid-17-alkylcarbonates, process for preparing thereof and pharmaceutical preparations
HUP0002952A3 (en) Benzimidazole derivatives, process for producing them, their use and pharmaceutical compositions containing them
FI930633A7 (en) Benzimidazole derivatives, process for their preparation and use
EP0449026A3 (en) Desoxynojirimycin derivatives, process for their preparation and their use in drugs
ZA911538B (en) New benzimidazole derivatives,process for their production and their pharmaceutical use
CS265391A3 (en) Novel thienodiazepines, process for their preparation and pharmaceutical comprising them
GB9121776D0 (en) Benzimidazole derivatives and process for preparation thereof
ZA884878B (en) Substituted benzimidazoles,a process for the preparation thereof,pharmaceutical formulations containing them,and the use thereof
FI942912L (en) Substituted benzimidazoles, process for their preparation and use
IL111707A0 (en) Substituted benzimidazole, processes for its preparation and its pharmaceutical use
IL97859A0 (en) 1,5-benzothiazepinone derivatives,their preparation and pharmaceutical use
EP0473267A3 (en) Acylaminopyridinecarboxamides, process for their preparation and their use as fungicides
ZA908300B (en) Benzimidazole derivatives,their production and use
EP0459198A3 (en) Thioalkanones, procedure for their preparation and their use
ZA902695B (en) Benzimidazoles,medicaments containing these compounds and processes for their preparation
GB2234748B (en) Quinoline derivatives, process for their preparation and their use as medicaments
EP0477717A3 (en) New 3-substituted cephalosporins, process for their preparation and their use as medicinal preparations
EP0583698A3 (en) Deoxycyclitol derivatives, process for their preparation and their use in medicaments.
IL101103A0 (en) Physiologically active kanglemycin c,process for preparing the same and use thereof